Kristen Laguerre, M.B.A.

Kristen Laguerre, an accomplished operating executive, is Partner, Finance and Operations at MPM BioImpact.  With 25 years of financial leadership and management experience in the venture capital industry, her primary responsibility is to oversee the firm’s finance, operations and administrative functions. Kristen is also an investment committee member of a number of MPM BioImpact funds. Kristen recently served as interim CFO at portfolio company ReNAgade Therapeutics (acquired by Orna) and was previously at portfolio company Cullinan Oncology (NASDAQ: CGEM).

Prior to joining MPM BioImpact, Kristen served as Partner and CFO at Flare Capital Partners, and, previously, Partner and CFO at Atlas Venture, an early-stage life sciences and technology venture capital firm, where she was responsible for finance, operations and administration. Before Atlas Venture, she was Vice President – Finance at Softbank Capital, where she was responsible for finance, human resources and operations associated with both Softbank’s venture funds and its global activities outside of East Asia. Earlier in her career, Kristen spent seven years at Arthur Andersen LLP.

Kristen earned her M.B.A. in Finance and Accounting from Boston University and her B.A. in Economics from Wesleyan University.